Henan Cancer Hospital: Neoplasms trials

The registry lists 11 Neoplasms studies with Henan Cancer Hospital as lead sponsor. 7 are open to participants now and 0 have results posted.

Early Phase 1 1Phase 1 2Phase 2 3Phase 3 1No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Clinical Trial of HRS-4642 Plus SHR-A2102 in Patients With Advanced Solid TumorsNot yet recruitingNCT06955390Phase 1/2
• Assessment of Safety and Efficacy of ThisCART19A in Adult Patients With B Cell Malignancies After Failure of Autologous Chimeric Antigen Receptor T- Cell(CAR-T) TherapyNot yet recruitingNCT05640713Phase 1
• Application of 3D Printed Prosthesis in Limb Salvage Surgery for Bone TumorsNot yet recruitingNCT05616195
• Application of LARS Ligament in Bone Prosthesis ReplacementNot yet recruitingNCT05616182
• Application of Douyin in Patients With Bone and Soft Tissue Malignant Tumors During PerichemotherapyNot yet recruitingNCT05598827Not applicable
• Application of Douyin in Perioperative Period of Malignant Tumor PatientsNot yet recruitingNCT05598229Not applicable
• Long-term Follow-up of Anxiety and Depression in Patients With Malignant TumorsRecruitingNCT05596344
• Prospective Phase II Clinical Study of Neoadjuvant Chemoradiotherapy Combined With PD-1/PD-L1 Inhibitors in the Treatment of Locally Advanced Resectable Esophageal Squamous Cell CarcinomaActive, not recruitingNCT06888531Phase 2
• RD13-02 for Patients With r/r CD7+ T Cell Hematologic MalignanciesCompletedNCT05923541Early Phase 1
• L-TIL in Patients With Malignancy Resistance to Anti-PD-1 TherapyStatus unknownNCT04268108
• Clinical Study on the Second-line and Above Treatment of Advanced Solid Tumor With Anlotinib Combined With Pd-1 AntibodyStatus unknownNCT03975036Phase 2/3